Certara launches secondary intelligence™ software to predict risk of unwanted side effects of drug candidates earlier

First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress first-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress

CERT Ratings Summary

CERT Quant Ranking